Abstract: HomeCirculationVol. 107, No. 1News From the American Heart Association Free AccessNewsPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessNewsPDF/EPUBNews From the American Heart Association Originally published7 Jan 2003https://doi.org/10.1161/01.CIR.0000051851.79624.42Circulation. 2003;107:B1AHA Issues New ProductsThe following new products for the public and the healthcare professional are available through your local American Heart Association or by calling 1-800-AHAUSA1.Your Child’s Abnormal Heart Rhythm: Our Guide for Parents of Children With Heart Rhythm Disturbances. This 23-page brochure discusses how the heart works, the most common heart rate abnormalities, and how your doctor may diagnose and treat such problems. It describes several common types of tachycardias and bradycardias and the special tests used to diagnose them. Updated 2002 version. Product code 50-1401A.An Active Partnership for the Health of Your Heart: Our Guide to Reducing Your Risk of Another Event. This 102-page reader-friendly workbook is packed with information and advice for regaining and maintaining heart health following a cardiac event. It features a new 4-color cover and new photography throughout. The workbook includes sections on understanding heart disease, eating right, exercising, managing stress, and avoiding smoking. There are sample menus and exercise programs, checklists and questionnaires for readers to complete, stop-smoking plans, medication-tracking forms, and much more. Also includes a removable wall chart for tracking one’s progress. Updated 2002 version. Product code 64-9608A.Guidelines for Prevention of Cardiovascular Disease. This 3”×8½”, 4-fold brochure includes the guidelines summary of the “Primary Prevention of Cardiovascular Diseases: 2002 Update” and “Secondary Prevention for Patients With Coronary and Other Vascular Disease: 2001 Update.” Product code 70-1206A.ACC/AHA Clinical Competence Statement on Electrocardiography and Ambulatory Electrocardiography. This competence statement is one in a series developed by the ACC and AHA to assist in the assessment of physicians’ competence on a procedure-specific basis. The minimum education, training, experiences, and cognitive and technical skills necessary for the competent reading and interpretation of electrocardiograms (ECGs) and ambulatory electrocardiograms (AECGs) are specified. Product code 71-0217.ACC/AHA Guidelines: Update on Perioperative Cardiac Evaluation for Noncardiac Surgery. Perioperative cardiac assessment is one of the best and most cost-effective ways to reduce risk—and now cardiologists have an updated tool to help with the job. The “ACC/AHA Guidelines for Perioperative Cardiovascular Evaluation for Noncardiac Surgery” have been extensively revised since their creation in 1996. They now reflect a wealth of new evidence on how best to evaluate and manage cardiac patients immediately before and after surgery. Product code 71-0220.AHA Scientific Statement: Unique Features of Infective Endocarditis in Childhood. This paper covers the topic of infective endocarditis in children. It discusses the epidemiology and clinical findings, pathophysiology, diagnostic tools, laboratory findings (including echocardiography and blood cultures), antimicrobial treatment, and prevention of this disease. Product code 71-0223.AHA Scientific Statement: Secondary Prevention of Coronary Heart Disease in the Elderly. As the US population ages, prevalence of CHD in the elderly increases. Clinical manifestations in older patients represent the effects of the disease superimposed on the physiological effects of aging. This publication focuses on secondary prevention interventions to impact and control risk factors in older patients with CHD, including smoking, hypertension, abnormal blood lipids, elevated blood glucose, obesity, various psychological concerns, and physical inactivity. A description of CHD in the elderly is also included. Product code 71-0224.AHA Scientific Statement: Prevention Conference VI: Diabetes and Cardiovascular Disease. A report on Diabetes and Cardiovascular Disease based on working group discussions and preceding presentations at Prevention VI Conference. It constitutes a review of cardiovascular disease in patients with diabetes, including epidemiology, pathogenesis of atherosclerosis, risk assessment in diabetics, lifestyle and medical management of risk factors, management of cardiovascular-renal complications, and revascularization in diabetic patients. Product code 77-0225.AHA Scientific Statement: Primary Prevention of Cardiovascular Disease. This guide is intended to assist primary-care providers in their assessment, management, and follow-up of patients who may be at risk for, but who have not yet manifested, cardiovascular disease. The continuing message is that adoption of healthy life habits remains the cornerstone of primary prevention, including the avoidance of tobacco, healthy dietary patterns, weight control, and regular, appropriate exercise. The healthcare professional should create an environment supportive of risk-factor change, including long-term reinforcement of adherence to lifestyle and drug interventions. Product code 71-0226.AHA Scientific Statement: Dietary Sugar and Cardiovascular Disease. The report contains a review of the impact of dietary sugar on health, with emphasis on cardiovascular disease and its risk factors. It provides a rationale for limiting sugar intake. Product code 71-0230.AHA Scientific Statement: Reporting of Renal Artery Revascularization. Although the treatment of atherosclerotic renal artery stenosis using percutaneous intravascular stents has gained widespread utility, there exist few prospective randomized controlled trials to support the regulatory approval of these devices. To facilitate this process and to help answer many important questions regarding the appropriate application of renal artery stents, well-designed and rigorously conducted trials are needed. These trials must have clearly defined goals and must be sufficiently sized and performed so as to withstand intensive outcomes assessment. Toward this end, this document provides guidelines and definitions for the design, conduct, evaluation, and reporting of renal artery stent randomized controlled trials. In addition, areas of critically necessary renal artery stent investigation are identified. It is hoped that this information will be valuable to the investigator wishing to conduct research in this important area. Product code 71-0235. Previous Back to top Next FiguresReferencesRelatedDetailsCited By Almenar L, Delgado J, Crespo M and Segovia J (2010) Situación actual del trasplante cardiaco en España, Revista Española de Cardiología, 10.1016/S0300-8932(10)70146-9, 63, (132-149), Online publication date: 1-Jan-2010. Crespo Leiro M, Almenar Bonet L, Alonso-Pulpón L, Campreciós M, Cuenca Castillo J, de la Fuente Galván L, Delgado Jiménez J, García Guereta L, Manito Lorite N, Maroto C, Palomo J, Pascual Figal D, Lage Gallé E, Rodríguez Lambert J, Roig i Minguell E, Sanz Julve M and Vázquez de Prada J (2007) Conferencia de Consenso de los Grupos Españoles de Trasplante Cardiaco, Revista Española de Cardiología Suplementos, 10.1016/S1131-3587(07)75240-8, 7:2, (4B-54B), Online publication date: 1-Jan-2007. Martínez De Morentin B, Rodríguez M and Martínez J (2003) Síndrome metabólico, resistencia a la insulina y metabolismo tisular, Endocrinología y Nutrición, 10.1016/S1575-0922(03)74546-X, 50:8, (324-333), Online publication date: 1-Jan-2003. January 7, 2003Vol 107, Issue 1 Advertisement Article InformationMetrics https://doi.org/10.1161/01.CIR.0000051851.79624.42 Originally publishedJanuary 7, 2003 PDF download Advertisement